THE promotion of any product making therapeutic claims -- from alternative treatments to mainstream pharmaceuticals -- should be policed under the scrutiny of one national body, the Federal Government has been warned.The rules surrounding the promotion of therapeutic goods is being examined by a government committee, following long-running concerns that companies that mislead health professionals and the public about the efficacy and safety of their products were escaping sanctions. In a submission to the inquiry, the Public Health Association of Australia called for root and branch reform, arguing there needed to be a therapeutic goods promotional authority to monitor products being marketed.It claimed that although the sector was currently dominated by a "plethora of industry sector code and complaint committees",...
The content on this site is available to Australian Registered Health Practitioners only. Please login or register for access.